Cargando…

Dose of colistin: a work in progress?

Detalles Bibliográficos
Autores principales:	Rocco, Monica, Montini, Luca, De Pascale, Gennaro, Antonelli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331303/ https://www.ncbi.nlm.nih.gov/pubmed/25887411 http://dx.doi.org/10.1186/s13054-015-0743-x

Ejemplares similares

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
por: Rocco, Monica, et al.
Publicado: (2013)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

The place of dexmedetomidine light sedation in patients with acute brain injury
por: Carelli, Simone, et al.
Publicado: (2019)

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features
por: De Pascale, Gennaro, et al.
Publicado: (2023)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Management with colistin
por: Singh, Harkirat
Publicado: (2010)

Renin–angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report
por: Eleuteri, Davide, et al.
Publicado: (2021)

The significance of different formulations of aerosolized colistin
por: Michalopoulos, Argyris, et al.
Publicado: (2005)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Acute kidney injury: taking aim at colistin
por: Rashid, Shayan, et al.
Publicado: (2014)

Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2020)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19
por: Grieco, Domenico Luca, et al.
Publicado: (2022)

Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
por: van den Anker, John N., et al.
Publicado: (2009)

Aquaculture and mcr Colistin Resistance Determinants
por: Cabello, Felipe C., et al.
Publicado: (2017)

Dose Optimization of Colistin: A Systematic Review
por: Haseeb, Abdul, et al.
Publicado: (2021)

Lice, rodents, and many hopes: a rare disease in a young refugee
por: Cutuli, Salvatore L., et al.
Publicado: (2017)

CO(2) driven endotracheal tube cuff control in critically ill patients: A randomized controlled study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

Clinical review: Noninvasive ventilation in the clinical setting – experience from the past 10 years
por: Antonelli, Massimo, et al.
Publicado: (2005)

Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
por: Menga, Luca S., et al.
Publicado: (2021)

Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial
por: Pennisi, Mariano Alberto, et al.
Publicado: (2019)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin
por: Singh, Rajesh K., et al.
Publicado: (2017)

Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome
por: Yagmur, Rezzan, et al.
Publicado: (2006)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case–control study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial
por: Cisneros, José M., et al.
Publicado: (2019)

Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
por: Kong, Jingchun, et al.
Publicado: (2023)

Emerging colistin resistance in Salmonella enterica serovar Newport isolates from human infections
por: Elbediwi, Mohammed, et al.
Publicado: (2020)

Vitamin D status in critically ill patients: the evidence is now bioavailable!
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges
por: Hamel, Mouna, et al.
Publicado: (2021)

Colistin Loading Dose in Septic Patients with Gram Negative Infections
por: Alshaya, Abdulrahman I, et al.
Publicado: (2022)

Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235
por: Vatansever, Cansel, et al.
Publicado: (2020)

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation
por: De Pascale, Gennaro, et al.
Publicado: (2022)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022)

Spread of mcr-1–Driven Colistin Resistance on Hospital Surfaces, Italy
por: Caselli, Elisabetta, et al.
Publicado: (2018)

mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France
por: Caspar, Yvan, et al.
Publicado: (2017)

Hypothetical Protein gene1038 Contributes to Colistin Resistance in Aeromonas hydrophila
por: Liu, Junqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu1ufrrhqsgel7hcgkkb7b7tqd